TALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.
from Medical Xpress - latest medical and health news stories https://ift.tt/ni1GgIv
